TY - JOUR
T1 - LINE-1 DNA methylation, smoking and risk of Parkinson's disease
AU - Nielsen, Susan Searles
AU - Checkoway, Harvey
AU - Butler, Rondi A.
AU - Nelson, Heather H.
AU - Farin, Federico M.
AU - Longstreth, W. T.
AU - Franklin, Gary M.
AU - Swanson, Phillip D.
AU - Kelsey, Karl T.
PY - 2012
Y1 - 2012
N2 - Background: Long interspersed nucleotide element-1 (LINE-1) retrotransposons are located throughout the human genome. Those retaining an intact 5′ promoter can copy and insert themselves into the DNA of neural progenitor cells that express tyrosine hydroxylase, which may influence differentiation and survival of these cells. LINE-1 promoter methylation is associated with decreased LINE-1 propagation. Objective: To investigate whether LINE-1 promoter methylation is associated with Parkinson's disease (PD). Methods: We compared LINE-1 methylation profiles in blood mononuclear cells between 292 newly diagnosed PD cases and 401 unrelated, neurologically normal controls, all non-Hispanic Caucasians in western Washington state. Results: Overall, PD was not associated with percent methylation of the LINE-1 promoter. However, the predictable inverse association between PD and ever smoking tobacco was strongest for men and women with the lowest LINE-1 promoter methylation, and less apparent as LINE-1 methylation increased. Underlying this possible interaction, ever regularly smoking tobacco was associated with decreased LINE-1 methylation in controls (age- and sex-adjusted linear regression β = -0.24, 95% confidence interval [CI] -0.43, -0.04), but not in cases (β = 0.06, 95% CI -0.17, 0.28, interaction p = 0.06). Conclusion: PD cases may have innate differences in their ability to respond to tobacco smoke.
AB - Background: Long interspersed nucleotide element-1 (LINE-1) retrotransposons are located throughout the human genome. Those retaining an intact 5′ promoter can copy and insert themselves into the DNA of neural progenitor cells that express tyrosine hydroxylase, which may influence differentiation and survival of these cells. LINE-1 promoter methylation is associated with decreased LINE-1 propagation. Objective: To investigate whether LINE-1 promoter methylation is associated with Parkinson's disease (PD). Methods: We compared LINE-1 methylation profiles in blood mononuclear cells between 292 newly diagnosed PD cases and 401 unrelated, neurologically normal controls, all non-Hispanic Caucasians in western Washington state. Results: Overall, PD was not associated with percent methylation of the LINE-1 promoter. However, the predictable inverse association between PD and ever smoking tobacco was strongest for men and women with the lowest LINE-1 promoter methylation, and less apparent as LINE-1 methylation increased. Underlying this possible interaction, ever regularly smoking tobacco was associated with decreased LINE-1 methylation in controls (age- and sex-adjusted linear regression β = -0.24, 95% confidence interval [CI] -0.43, -0.04), but not in cases (β = 0.06, 95% CI -0.17, 0.28, interaction p = 0.06). Conclusion: PD cases may have innate differences in their ability to respond to tobacco smoke.
KW - DNA methylation
KW - idiopathic Parkinson's disease
KW - long interspersed nucleotide elements
KW - smoking
UR - http://www.scopus.com/inward/record.url?scp=84874845545&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84874845545&partnerID=8YFLogxK
U2 - 10.3233/JPD-012129
DO - 10.3233/JPD-012129
M3 - Article
C2 - 23938260
AN - SCOPUS:84874845545
VL - 2
SP - 303
EP - 308
JO - Journal of Parkinson's Disease
JF - Journal of Parkinson's Disease
SN - 1877-7171
IS - 4
ER -